Endothelial progenitor cells transfected with PDGF: Cellular and molecular targets for prevention of diabetic microangiopathy
Open Access
- 31 December 2006
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 67 (6) , 1308-1312
- https://doi.org/10.1016/j.mehy.2006.05.033
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- G‐CSF‐mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capabilityJournal of Thrombosis and Haemostasis, 2006
- Diabetic Microangiopathy in Ischemic Limb Is a Disease of Disturbance of the Platelet-Derived Growth Factor-BB/Protein Kinase C Axis but Not of Impaired Expression of Angiogenic FactorsCirculation Research, 2006
- Update on therapeutic neovascularizationCardiovascular Research, 2005
- Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantationThrombosis and Haemostasis, 2004
- The challenges of treating peripheral arterial diseaseVascular Medicine, 2003
- Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth FactorsCirculation, 2003
- Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2Circulation, 2002
- Blood-derived angioblasts accelerate blood-flow restoration in diabetic miceJournal of Clinical Investigation, 2000
- Blood vessel maturation: vascular development comes of ageJournal of Clinical Investigation, 1999
- PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle FateThe Journal of cell biology, 1998